Roche’s virtual event following ASH 2021
Roche has hosted a virtual event on Wednesday, 15 December 2021.
| Agenda | |
|---|---|
| Welcome | Karl Mahler, Head of Investor Relations |
| Hematology Franchise Overview | Peter Ahnesorg, Franchise Head Hematology |
| Review of Key Clinical Data Presented at ASH: Hemlibra, mosun, glofit, cevostamab | Charles Fuchs, Senior Vice President - Global Head Of Oncology And Hematology Product Development |
| Presentation of POLARIX data | Franck Morschhauser, MD, PhD, Professor of Hematology, University of Lille; President of LYSA, LYSARC |
| Q&A |
Webinar Replay
Investors